nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—NR3C2—dilated cardiomyopathy	0.356	1	CbGaD
Betamethasone—NR3C2—Spironolactone—dilated cardiomyopathy	0.164	0.467	CbGbCtD
Betamethasone—PGR—Spironolactone—dilated cardiomyopathy	0.106	0.302	CbGbCtD
Betamethasone—Testolactone—Spironolactone—dilated cardiomyopathy	0.0685	0.282	CrCrCtD
Betamethasone—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.063	0.259	CrCrCtD
Betamethasone—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.0614	0.253	CrCrCtD
Betamethasone—NR3C1—Spironolactone—dilated cardiomyopathy	0.0539	0.154	CbGbCtD
Betamethasone—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.05	0.206	CrCrCtD
Betamethasone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0143	0.0408	CbGbCtD
Betamethasone—ABCB1—Spironolactone—dilated cardiomyopathy	0.0126	0.0359	CbGbCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.00259	0.173	CbGpPWpGaD
Betamethasone—Hypertrichosis—Spironolactone—dilated cardiomyopathy	0.002	0.0585	CcSEcCtD
Betamethasone—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00153	0.045	CcSEcCtD
Betamethasone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00137	0.0402	CcSEcCtD
Betamethasone—Hypotensive—Furosemide—dilated cardiomyopathy	0.00113	0.0332	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.00109	0.0725	CbGpPWpGaD
Betamethasone—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.000992	0.0291	CcSEcCtD
Betamethasone—Diabetic—Lisinopril—dilated cardiomyopathy	0.000929	0.0272	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.000927	0.0619	CbGpPWpGaD
Betamethasone—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.000895	0.0262	CcSEcCtD
Betamethasone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000864	0.0253	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.000835	0.0558	CbGpPWpGaD
Betamethasone—Ulcer—Spironolactone—dilated cardiomyopathy	0.000803	0.0235	CcSEcCtD
Betamethasone—PLA2G1B—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.0008	0.0535	CbGpPWpGaD
Betamethasone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000778	0.0228	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000587	0.0393	CbGpPWpGaD
Betamethasone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000583	0.366	CrCbGaD
Betamethasone—Blister—Furosemide—dilated cardiomyopathy	0.000573	0.0168	CcSEcCtD
Betamethasone—Lethargy—Spironolactone—dilated cardiomyopathy	0.000563	0.0165	CcSEcCtD
Betamethasone—Blindness—Lisinopril—dilated cardiomyopathy	0.00056	0.0164	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.000558	0.0373	CbGpPWpGaD
Betamethasone—Glycosuria—Furosemide—dilated cardiomyopathy	0.00051	0.0149	CcSEcCtD
Betamethasone—PGR—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000508	0.034	CbGpPWpGaD
Betamethasone—Vasculitis—Furosemide—dilated cardiomyopathy	0.000423	0.0124	CcSEcCtD
Betamethasone—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.000411	0.0275	CbGpPWpGaD
Betamethasone—Fluticasone Propionate—NR3C2—dilated cardiomyopathy	0.00041	0.257	CrCbGaD
Betamethasone—PGR—Nuclear signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000383	0.0256	CbGpPWpGaD
Betamethasone—Prednisolone—NR3C2—dilated cardiomyopathy	0.000383	0.24	CrCbGaD
Betamethasone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000346	0.0102	CcSEcCtD
Betamethasone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000345	0.0101	CcSEcCtD
Betamethasone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.000341	0.00999	CcSEcCtD
Betamethasone—Alopecia—Spironolactone—dilated cardiomyopathy	0.000337	0.00988	CcSEcCtD
Betamethasone—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00033	0.00967	CcSEcCtD
Betamethasone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000318	0.00931	CcSEcCtD
Betamethasone—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000314	0.0092	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00031	0.00908	CcSEcCtD
Betamethasone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000308	0.00903	CcSEcCtD
Betamethasone—Lethargy—Furosemide—dilated cardiomyopathy	0.000306	0.00897	CcSEcCtD
Betamethasone—Malaise—Spironolactone—dilated cardiomyopathy	0.000299	0.00877	CcSEcCtD
Betamethasone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000294	0.00862	CcSEcCtD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.000294	0.0196	CbGpPWpGaD
Betamethasone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000291	0.00853	CcSEcCtD
Betamethasone—Irritability—Furosemide—dilated cardiomyopathy	0.000286	0.00839	CcSEcCtD
Betamethasone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000279	0.00818	CcSEcCtD
Betamethasone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000276	0.00809	CcSEcCtD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000275	0.0184	CbGpPWpGaD
Betamethasone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000273	0.008	CcSEcCtD
Betamethasone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000271	0.00794	CcSEcCtD
Betamethasone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000265	0.00777	CcSEcCtD
Betamethasone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000265	0.00775	CcSEcCtD
Betamethasone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000259	0.00758	CcSEcCtD
Betamethasone—Injury—Lisinopril—dilated cardiomyopathy	0.000245	0.00717	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000234	0.00685	CcSEcCtD
Betamethasone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000234	0.00685	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000233	0.00681	CcSEcCtD
Betamethasone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000225	0.00659	CcSEcCtD
Betamethasone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000223	0.00654	CcSEcCtD
Betamethasone—Dexamethasone—NR3C2—dilated cardiomyopathy	0.000218	0.137	CrCbGaD
Betamethasone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000215	0.00631	CcSEcCtD
Betamethasone—Irritability—Lisinopril—dilated cardiomyopathy	0.000215	0.00629	CcSEcCtD
Betamethasone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000214	0.00628	CcSEcCtD
Betamethasone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000214	0.00627	CcSEcCtD
Betamethasone—Visual impairment—Furosemide—dilated cardiomyopathy	0.0002	0.00586	CcSEcCtD
Betamethasone—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000194	0.013	CbGpPWpGaD
Betamethasone—Eye disorder—Furosemide—dilated cardiomyopathy	0.000194	0.00568	CcSEcCtD
Betamethasone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000192	0.00562	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000191	0.0128	CbGpPWpGaD
Betamethasone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000189	0.00555	CcSEcCtD
Betamethasone—Angiopathy—Furosemide—dilated cardiomyopathy	0.000188	0.00552	CcSEcCtD
Betamethasone—CYP19A1—FSH signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000188	0.0125	CbGpPWpGaD
Betamethasone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000185	0.00543	CcSEcCtD
Betamethasone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000185	0.00543	CcSEcCtD
Betamethasone—Erythema—Furosemide—dilated cardiomyopathy	0.000181	0.00529	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00018	0.012	CbGpPWpGaD
Betamethasone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000179	0.00525	CcSEcCtD
Betamethasone—Weight increased—Lisinopril—dilated cardiomyopathy	0.000177	0.00519	CcSEcCtD
Betamethasone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000176	0.00516	CcSEcCtD
Betamethasone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000175	0.00514	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000173	0.0116	CbGpPWpGaD
Betamethasone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000172	0.00505	CcSEcCtD
Betamethasone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000171	0.00501	CcSEcCtD
Betamethasone—Rash—Spironolactone—dilated cardiomyopathy	0.000171	0.00501	CcSEcCtD
Betamethasone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000171	0.005	CcSEcCtD
Betamethasone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00017	0.00498	CcSEcCtD
Betamethasone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00017	0.00498	CcSEcCtD
Betamethasone—Headache—Spironolactone—dilated cardiomyopathy	0.00017	0.00497	CcSEcCtD
Betamethasone—Vertigo—Furosemide—dilated cardiomyopathy	0.000162	0.00476	CcSEcCtD
Betamethasone—Nausea—Spironolactone—dilated cardiomyopathy	0.000161	0.00472	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—RAF1—dilated cardiomyopathy	0.00016	0.0107	CbGpPWpGaD
Betamethasone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000158	0.00464	CcSEcCtD
Betamethasone—Hallucination—Lisinopril—dilated cardiomyopathy	0.000155	0.00454	CcSEcCtD
Betamethasone—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00015	0.01	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000147	0.00432	CcSEcCtD
Betamethasone—Shock—Furosemide—dilated cardiomyopathy	0.000145	0.00425	CcSEcCtD
Betamethasone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000145	0.00424	CcSEcCtD
Betamethasone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000144	0.00423	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000143	0.00957	CbGpPWpGaD
Betamethasone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000143	0.00418	CcSEcCtD
Betamethasone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000141	0.00414	CcSEcCtD
Betamethasone—Anorexia—Furosemide—dilated cardiomyopathy	0.000141	0.00412	CcSEcCtD
Betamethasone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000139	0.00408	CcSEcCtD
Betamethasone—Hypotension—Furosemide—dilated cardiomyopathy	0.000138	0.00404	CcSEcCtD
Betamethasone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000138	0.00403	CcSEcCtD
Betamethasone—Erythema—Lisinopril—dilated cardiomyopathy	0.000136	0.00397	CcSEcCtD
Betamethasone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000132	0.00388	CcSEcCtD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—dilated cardiomyopathy	0.000132	0.00882	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.000129	0.00863	CbGpPWpGaD
Betamethasone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000128	0.00376	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000127	0.00373	CcSEcCtD
Betamethasone—Fatigue—Furosemide—dilated cardiomyopathy	0.000127	0.00372	CcSEcCtD
Betamethasone—Pain—Furosemide—dilated cardiomyopathy	0.000126	0.00369	CcSEcCtD
Betamethasone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000126	0.00368	CcSEcCtD
Betamethasone—Angioedema—Lisinopril—dilated cardiomyopathy	0.000124	0.00363	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000124	0.00825	CbGpPWpGaD
Betamethasone—Malaise—Lisinopril—dilated cardiomyopathy	0.000122	0.00358	CcSEcCtD
Betamethasone—Vertigo—Lisinopril—dilated cardiomyopathy	0.000122	0.00357	CcSEcCtD
Betamethasone—Syncope—Lisinopril—dilated cardiomyopathy	0.000122	0.00356	CcSEcCtD
Betamethasone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000121	0.00356	CcSEcCtD
Betamethasone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000121	0.00353	CcSEcCtD
Betamethasone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000119	0.00349	CcSEcCtD
Betamethasone—Urticaria—Furosemide—dilated cardiomyopathy	0.000117	0.00343	CcSEcCtD
Betamethasone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000117	0.00341	CcSEcCtD
Betamethasone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000117	0.00341	CcSEcCtD
Betamethasone—Myalgia—Lisinopril—dilated cardiomyopathy	0.000115	0.00338	CcSEcCtD
Betamethasone—Anxiety—Lisinopril—dilated cardiomyopathy	0.000115	0.00337	CcSEcCtD
Betamethasone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000114	0.00334	CcSEcCtD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.000113	0.00756	CbGpPWpGaD
Betamethasone—CYP19A1—FSH signaling pathway—RAF1—dilated cardiomyopathy	0.000112	0.00751	CbGpPWpGaD
Betamethasone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000111	0.00324	CcSEcCtD
Betamethasone—Oedema—Lisinopril—dilated cardiomyopathy	0.000111	0.00324	CcSEcCtD
Betamethasone—Infection—Lisinopril—dilated cardiomyopathy	0.00011	0.00322	CcSEcCtD
Betamethasone—Shock—Lisinopril—dilated cardiomyopathy	0.000109	0.00319	CcSEcCtD
Betamethasone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000108	0.00317	CcSEcCtD
Betamethasone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000108	0.00316	CcSEcCtD
Betamethasone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000107	0.00313	CcSEcCtD
Betamethasone—Asthenia—Furosemide—dilated cardiomyopathy	0.000106	0.0031	CcSEcCtD
Betamethasone—Anorexia—Lisinopril—dilated cardiomyopathy	0.000105	0.00309	CcSEcCtD
Betamethasone—Pruritus—Furosemide—dilated cardiomyopathy	0.000104	0.00306	CcSEcCtD
Betamethasone—Hypotension—Lisinopril—dilated cardiomyopathy	0.000103	0.00303	CcSEcCtD
Betamethasone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000101	0.00296	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000101	0.00295	CcSEcCtD
Betamethasone—Insomnia—Lisinopril—dilated cardiomyopathy	0.0001	0.00293	CcSEcCtD
Betamethasone—Paraesthesia—Lisinopril—dilated cardiomyopathy	9.93e-05	0.00291	CcSEcCtD
Betamethasone—Dizziness—Furosemide—dilated cardiomyopathy	9.75e-05	0.00286	CcSEcCtD
Betamethasone—Dyspepsia—Lisinopril—dilated cardiomyopathy	9.74e-05	0.00285	CcSEcCtD
Betamethasone—Decreased appetite—Lisinopril—dilated cardiomyopathy	9.61e-05	0.00282	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	9.55e-05	0.0028	CcSEcCtD
Betamethasone—Fatigue—Lisinopril—dilated cardiomyopathy	9.54e-05	0.00279	CcSEcCtD
Betamethasone—Pain—Lisinopril—dilated cardiomyopathy	9.46e-05	0.00277	CcSEcCtD
Betamethasone—Vomiting—Furosemide—dilated cardiomyopathy	9.37e-05	0.00275	CcSEcCtD
Betamethasone—Rash—Furosemide—dilated cardiomyopathy	9.29e-05	0.00272	CcSEcCtD
Betamethasone—Dermatitis—Furosemide—dilated cardiomyopathy	9.29e-05	0.00272	CcSEcCtD
Betamethasone—Headache—Furosemide—dilated cardiomyopathy	9.23e-05	0.00271	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	9.16e-05	0.00612	CbGpPWpGaD
Betamethasone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	9.11e-05	0.00267	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	9.06e-05	0.00605	CbGpPWpGaD
Betamethasone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	9.04e-05	0.00265	CcSEcCtD
Betamethasone—Urticaria—Lisinopril—dilated cardiomyopathy	8.79e-05	0.00257	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	8.78e-05	0.00587	CbGpPWpGaD
Betamethasone—Nausea—Furosemide—dilated cardiomyopathy	8.76e-05	0.00257	CcSEcCtD
Betamethasone—Abdominal pain—Lisinopril—dilated cardiomyopathy	8.74e-05	0.00256	CcSEcCtD
Betamethasone—Body temperature increased—Lisinopril—dilated cardiomyopathy	8.74e-05	0.00256	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—ANKRD1—dilated cardiomyopathy	8.52e-05	0.00569	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—TAZ—dilated cardiomyopathy	8.01e-05	0.00535	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	7.94e-05	0.0053	CbGpPWpGaD
Betamethasone—Asthenia—Lisinopril—dilated cardiomyopathy	7.94e-05	0.00233	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	7.85e-05	0.00525	CbGpPWpGaD
Betamethasone—Pruritus—Lisinopril—dilated cardiomyopathy	7.83e-05	0.00229	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	7.75e-05	0.00517	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	7.63e-05	0.0051	CbGpPWpGaD
Betamethasone—Diarrhoea—Lisinopril—dilated cardiomyopathy	7.57e-05	0.00222	CcSEcCtD
Betamethasone—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.54e-05	0.00504	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	7.42e-05	0.00496	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	7.32e-05	0.00489	CbGpPWpGaD
Betamethasone—Dizziness—Lisinopril—dilated cardiomyopathy	7.31e-05	0.00214	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—SDHA—dilated cardiomyopathy	7.24e-05	0.00484	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	7.06e-05	0.00472	CbGpPWpGaD
Betamethasone—Vomiting—Lisinopril—dilated cardiomyopathy	7.03e-05	0.00206	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.98e-05	0.00467	CbGpPWpGaD
Betamethasone—Rash—Lisinopril—dilated cardiomyopathy	6.97e-05	0.00204	CcSEcCtD
Betamethasone—Dermatitis—Lisinopril—dilated cardiomyopathy	6.97e-05	0.00204	CcSEcCtD
Betamethasone—Headache—Lisinopril—dilated cardiomyopathy	6.93e-05	0.00203	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	6.67e-05	0.00445	CbGpPWpGaD
Betamethasone—Nausea—Lisinopril—dilated cardiomyopathy	6.57e-05	0.00193	CcSEcCtD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.57e-05	0.00439	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	6.5e-05	0.00434	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	6.15e-05	0.00411	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	5.52e-05	0.00369	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	5.49e-05	0.00367	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	5.08e-05	0.00339	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	5.03e-05	0.00336	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	4.91e-05	0.00328	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	4.82e-05	0.00322	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	4.8e-05	0.00321	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.67e-05	0.00312	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	4.62e-05	0.00309	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	4.57e-05	0.00305	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.42e-05	0.00295	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.39e-05	0.00293	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NPPA—dilated cardiomyopathy	4.36e-05	0.00291	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	4.34e-05	0.0029	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—RAF1—dilated cardiomyopathy	4.3e-05	0.00288	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.3e-05	0.00287	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	4.28e-05	0.00286	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NR3C2—dilated cardiomyopathy	4.23e-05	0.00283	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	4.18e-05	0.00279	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	4.06e-05	0.00271	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.87e-05	0.00259	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	3.87e-05	0.00259	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	3.6e-05	0.0024	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	3.48e-05	0.00233	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	3.47e-05	0.00232	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	3.36e-05	0.00225	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	3.2e-05	0.00214	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	3.19e-05	0.00213	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.11e-05	0.00208	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	3e-05	0.002	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—EGFR—dilated cardiomyopathy	2.95e-05	0.00197	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TAZ—dilated cardiomyopathy	2.92e-05	0.00195	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NPPA—dilated cardiomyopathy	2.66e-05	0.00177	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SDHA—dilated cardiomyopathy	2.64e-05	0.00177	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.51e-05	0.00167	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	2.44e-05	0.00163	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.42e-05	0.00161	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.37e-05	0.00158	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.24e-05	0.0015	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.18e-05	0.00146	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.18e-05	0.00146	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	2.08e-05	0.00139	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.03e-05	0.00135	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GPX1—dilated cardiomyopathy	1.97e-05	0.00131	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	1.95e-05	0.00131	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.95e-05	0.0013	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CD36—dilated cardiomyopathy	1.92e-05	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.91e-05	0.00127	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	1.84e-05	0.00123	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.78e-05	0.00119	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	1.77e-05	0.00118	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AGT—dilated cardiomyopathy	1.72e-05	0.00115	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.71e-05	0.00114	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.68e-05	0.00112	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.67e-05	0.00112	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.61e-05	0.00108	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.59e-05	0.00106	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	1.58e-05	0.00106	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.57e-05	0.00105	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.57e-05	0.00105	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	1.53e-05	0.00103	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	1.51e-05	0.00101	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.48e-05	0.000992	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.48e-05	0.000992	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.47e-05	0.000984	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.47e-05	0.000984	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.41e-05	0.000945	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.38e-05	0.000925	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.38e-05	0.000922	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.34e-05	0.000893	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.25e-05	0.000837	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.14e-05	0.000763	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.11e-05	0.000744	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.08e-05	0.000724	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NPPA—dilated cardiomyopathy	1.08e-05	0.000722	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.08e-05	0.00072	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.08e-05	0.00072	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.05e-05	0.000701	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PSEN2—dilated cardiomyopathy	1.05e-05	0.000699	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.03e-05	0.000685	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.45e-06	0.000631	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.31e-06	0.000622	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	9.08e-06	0.000606	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	8.53e-06	0.00057	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAC1—dilated cardiomyopathy	8.41e-06	0.000562	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGT—dilated cardiomyopathy	8.03e-06	0.000537	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.72e-06	0.000516	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	7.63e-06	0.00051	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.27e-06	0.000486	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPX1—dilated cardiomyopathy	7.18e-06	0.00048	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CD36—dilated cardiomyopathy	7e-06	0.000467	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AGT—dilated cardiomyopathy	6.3e-06	0.000421	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAF1—dilated cardiomyopathy	5.58e-06	0.000373	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RAC1—dilated cardiomyopathy	5.26e-06	0.000351	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	4.8e-06	0.000321	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CD36—dilated cardiomyopathy	4.67e-06	0.000312	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.42e-06	0.000295	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AGT—dilated cardiomyopathy	4.21e-06	0.000281	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—dilated cardiomyopathy	3.82e-06	0.000255	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RAF1—dilated cardiomyopathy	3.49e-06	0.000233	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.4e-06	0.000227	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.31e-06	0.000221	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.98e-06	0.000199	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—dilated cardiomyopathy	2.39e-06	0.00016	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.1e-06	0.00014	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.04e-06	0.000136	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.84e-06	0.000123	CbGpPWpGaD
